glp 1 drug mounjaro Use of the dual GIP/GLP-1 tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort Glp 1 drug hi-res stock

openPR disclaims liability for any content contained in this release

REWIND, Researching Cardiovascular Events With a Weekly Incretin in Diabetes

External resources PubMed - Weight regain after GLP-1 RA interruption: narrative review eClinicalMedicine - Metabolic rebound after GLP-1 RA discontinuation: meta-analysis For researchers navigating the complexities of GLP-1 treatment duration, SeekPeptides provides comprehensive protocol guides, dosing calculators , and evidence-based resources designed to help you make informed decisions about your treatment timeline

For those seeking more modest amounts of weight loss, any of the currently available medications are likely to work and the choice can be driven by a variety of factors: insurance coverage, availability, formulation (injection vs oral), and ease of access and use

Small variations in chemical structure, as well as different dosage and delivery methods, may affect how they are approved for use